Cutaneous Melanoma of the Extremity — Trials

Cutaneous Melanoma of the Extremity — Trials · CancerIndex

Clinical trials

Registered studies

31 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 15
Recruiting: 9
Ph III recruiting: 1
Growth YoY: —
Industry share: 7%
Top sponsor: Fred Hutchinson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05436990	Antitumor Activity of Vactosertib in Combination With Pembrolizumab in Acral and Mucosal Melanoma Patients Progressed From Prior Immune Check Point Inhibitor	terminated	Phase 2	14	Yonsei UniversityOTHER	1	Apr 2, 2025	clinicaltrials
NCT02978443	A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab	terminated	Phase 2	14	Georgetown UniversityOTHER	1	Apr 4, 2024	clinicaltrials